-
Primary Cell Optimization 384-well Nucleofector™ KitCatalog #: V5SP-9001For high-throughput optimization of transfection conditions for primary cell types lacking an Optimized Protocol for the 384-well HT NucleofectorTM SystemSales unit: items
-
Human CD19+ B Cells (10 Million Cells, Negative Selection)Catalog #: 4W-601
Human CD19+ B cells isolated from peripheral blood using negative immunomagnetic selection, cryopreserved, ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: each -
Human Bone Marrow Mononuclear Cells MNCs, Cryopreserved, 25 Million CellsCatalog #: 2M-125C
Cryopreserved ampule of Human Bone Marrow Mononuclear Cells containing ≥25 million cells
Sales unit: each -
Human Bone Marrow MNCs, Cryopreserved, 5 MillionCatalog #: 2S-101D
Cryopreserved ampule of Human Bone Marrow Mononuclear Cells containing ≥5 million cells
Sales unit: each -
hMSC Human Mesenchymal Stem Cell Chondrogenic Differentiation Basal MediumCatalog #: PT-3925hMSC Chondrogenic Differentiation Basal Medium, 185 mLSales unit: each
-
hMSC Human Mesenchymal Stem Cell Chondrogenic Differentiation Medium SingleQuotsTM Supplements and Growth FactorsCatalog #: PT-4121hMSC Chondrogenic Differentiation SingleQuotsTM KitSales unit: each
-
Trypsin Neutralizing Solution, 100 mLCatalog #: CC-5002
Trypsin Neutralizing Solution for use in cell culture, 100 mL
Sales unit: each -
Human Cord Blood CD34+ Progenitor Cells, Cryopreserved, 500,000 cellsCatalog #: 2C-101A
Cryopreserved ampule of Human Cord Blood CD34+ containing ≥500,000 cells
Sales unit: each -
HMVEC-dNeo – Human Dermal Microvascular Endothelial Cells, Neonatal, Single DonorCatalog #: CC-2505HMVEC-d Neo, Dermal Microvascular Endothelial, Neonatal, Single donorSales unit: each
-
NHDC - Human Dendritic CellsCatalog #: CC-2701
Cryopreserved ampule of Normal Human Dendritic Cells (NHDC) containing ≥2.5 million cells
Sales unit: each
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.